logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Tobias Gabriel

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • San Francisco, CA (US) (2004 - 2010)
  • Basel, CH (2011)

Company Filing History:

goldMedal14 out of 322 
 
Roche Palo Alto LLC
 patents
silverMedal1 out of 832,843 
Other
 patents

Years Active: 2004-2011

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7943618 - Btk protein kinase inhibitors (2011-05-17),
2. 7645764 - Kinase inhibitors and methods for using the same (2010-01-12),
3. 7608603 - Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase inhibitors (2009-10-27),
4. 7601726 - Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors (2009-10-13),
5. 7566708 - Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors (2009-07-28),
6. 7563800 - Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors (2009-07-21),
7. 7563799 - Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors (2009-07-21),
8. 7517901 - p38 MAP kinase inhibitors and methods for using the same (2009-04-14),
9. 7495015 - Indazole derivatives and methods for using the same (2009-02-24),
10. 7452880 - Substituted pyrazolo [3,4-d] pyrimidines and methods of using the same (2008-11-18),
11. 7435731 - Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same (2008-10-14),
12. 7358373 - Cathepsin K inhibitors (2008-04-15),
13. 7300934 - Benzamide nitriles (2007-11-27),
14. 6759428 - Indole nitriles (2004-07-06),
15. 6747053 - Heteroaryl nitriles (2004-06-08),

Title: **The Innovative Mind of Tobias Gabriel: Pioneering Kinase Inhibitors**

Introduction

Tobias Gabriel is a distinguished inventor based in San Francisco, CA, whose contributions to biotechnology have garnered him an impressive portfolio of 15 patents. His work primarily focuses on the development of compounds that inhibit Btk protein kinase, making significant strides in the treatment of diseases linked to autoimmunity and inflammation.

Latest Patents

Among Gabriel's latest patents, the application for Btk protein kinase inhibitors stands out. This innovative application discloses a series of pyridine and pyrimidine compounds designed to inhibit Btk activity. The compounds are formulated to modulate Btk’s action, offering therapeutic potential for conditions characterized by excessive Btk activity, such as rheumatoid arthritis. Additionally, another significant patent addresses kinase inhibitors, detailing methods for synthesizing these compounds and their use in treating diseases related to p38 MAP kinase and Raf kinase.

Career Highlights

Tobias Gabriel has made remarkable contributions to the field of biotechnology during his career, with substantial experience at Roche Palo Alto LLC. His expertise and innovative approach have played a crucial role in advancing the understanding and treatment of complex diseases through targeted compounds.

Collaborations

Throughout his career, Gabriel has collaborated with notable colleagues, including Nolan James Dewdney and Michael Soth. These partnerships have enriched his research endeavors, fostering an environment of innovation and scientific advancement.

Conclusion

Tobias Gabriel exemplifies the spirit of innovation in the biotechnology sector. His dedication to developing effective therapies through his patents and collaborative efforts continues to impact the treatment landscape for inflammatory and autoimmune diseases. His work not only showcases his ingenuity as an inventor but also highlights the importance of collaboration in driving scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…